These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 15907990
1. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. White DA, Hwang ML, Holtzman SG. Pharmacol Biochem Behav; 2005 Jul; 81(3):451-8. PubMed ID: 15907990 [Abstract] [Full Text] [Related]
4. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence. Jin C, Araki H, Nagata M, Shimosaka R, Shibata K, Suemaru K, Kawasaki H, Gomita Y. Behav Brain Res; 2005 Jun 03; 161(1):107-12. PubMed ID: 15904717 [Abstract] [Full Text] [Related]
8. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure. Jin C, Araki H, Kawasaki Y, Nagata M, Suemaru K, Shibata K, Hamamura T, Kawasaki H, Gomita Y. Brain Res; 2006 Jan 19; 1069(1):120-6. PubMed ID: 16360647 [Abstract] [Full Text] [Related]
9. Barium potentiates the conditioned aversion to, but not the somatic signs of, morphine withdrawal in mice. Sato M, Wada K, Funada M. Eur J Pharmacol; 2005 Sep 20; 519(3):215-22. PubMed ID: 16122731 [Abstract] [Full Text] [Related]
14. Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat. Easterling KW, Holtzman SG. J Pharmacol Exp Ther; 1999 Mar 20; 288(3):1269-77. PubMed ID: 10027868 [Abstract] [Full Text] [Related]
18. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization. White DA, Holtzman SG. J Pharmacol Exp Ther; 2005 Jul 20; 314(1):374-82. PubMed ID: 15843500 [Abstract] [Full Text] [Related]
19. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area. Rezayof A, Nazari-Serenjeh F, Zarrindast MR, Sepehri H, Delphi L. Eur J Pharmacol; 2007 May 07; 562(1-2):92-102. PubMed ID: 17336285 [Abstract] [Full Text] [Related]